Pioneering Changes in Psychiatry: Biomarkers, Psychedelics, and AI.
ACS Med Chem Lett August 18, 2023 DOI: 10.1021/acsmedchemlett.3c00333 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Mental health Personalized medicine Medical innovation Ai in healthcare |
| Citations | 3 |
| Key points | Integrating biomarkers, psychedelics, and AI could enhance personalized psychiatric care, but challenges must be addressed. |
Abstract
This viewpoint discusses integrating biomarkers, psychedelics, and AI into psychiatry for enhanced diagnostics, prognosis, and treatment. It highlights the potential of psychedelics in therapy, AI's role in predicting treatment response, and the challenges that must be addressed. The aim is to encourage research for more precise, personalized psychiatric care.